A descriptive study of genotype-phenotype characteristics of children with autism spectrum disorder with coexisting epilepsy
Epilepsy 55 0
A descriptive study of genotype-phenotype characteristics of children with autism spectrum disorder with coexisting epilepsy Sudhakar k , Ramshekhar Menon, Muralidharan Nair , Soumya Sundaram Autism spectrum disorder and epilepsy co-exists in many patients, suggesting a common etio-pathological basis. The recent advances in the understanding of molecular mechanisms of autism and unraveling of various genes have provided a link between epilepsy and autism.This is a retrospective descriptive analysis of 13 patients under 18 years of age who were diagnosed with ASD (based on DSM V criteria) and coexisting epilepsy.This study analyzed the...
CNS Infections 5822 0
Zika virus is a mosquito-borne flavivirus primarily transmitted by Aedes aegypti mosquitoes (Hayes, 2009; CDC, 2016 ) and to a lesser extent by Aedes albopictus mosquitoes.
Epilepsy 3503 0
see Neonatal seizures
Epilepsy 5832 0
The International League Against Epilepsy (ILAE) Commission on Classiﬁcation and Terminology has revised concepts, terminology, and approaches for classifying seizures and forms of epilepsy.
Neonatal Neurology 12570 0
Neonatal epileptic seizures occur from birth to the end of the neonatal period.This is the most vulnerable of all the other periods of life for the development of epileptic seizures, particularly in the first 1 or 2 days from birth. Neonatal seizures differ from those of older children and adults. They may be short-lived events lasting for just a few days, but they often signify serious malfunction or damage of the immature brain, and constitute a neurological emergency that demands urgent diagnosis and management. Most neonatal seizures are acute (pro-voked, occasional, reactive) symptomatic seizures caused by an acute illness...
Pharmacopoeia 5415 0
Zonisamide is a synthetic 1,2-benzisoxazole derivative (1,2-benzisoxazole-3-methanesulfonamide).
Pharmacopoeia 6058 0
Vigabatrin (γ-vilyl-GABA; 4-amino-hex-5-enoic acid) was a result of a rational approach to design compounds that enhance the effect of the inhibitory neurotransmitter GABA.1-16
Pharmacopoeia 10593 0
Levetiracetam is a single enantiomer, (S)-α-ethyl-2-oxo-pyrrolidine acetamide. Levetiracetam, licensed in 1999, is probably the best of all the newer AEDs1-7. It is chemically unrelated to any of the other current AEDs.
Pharmacopoeia 26993 0
Lamotrigine is a 3,5-diamino-6-(2,3-dichlorophenyl)-as-triazine of the phenyltriazine class. It was first licensed for clinical practice in 1991. Lamotrigine is one of the best newer AEDs, although there are now concerns for its use in women and myoclonic epilepsies.
Pharmacopoeia 21968 0
Lacosamide is a functionalized amino acid (R)-2-acetamido-N-benzyl-3-methoxypropionamide. It is one of the latest AEDs to be licensed (at the end of 2008), under the brand name Vimpat.